These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 26772401)

  • 1. Integrin α5 promotes tumor progression and is an independent unfavorable prognostic factor in esophageal squamous cell carcinoma.
    Xie JJ; Guo JC; Wu ZY; Xu XE; Wu JY; Chen B; Ran LQ; Liao LD; Li EM; Xu LY
    Hum Pathol; 2016 Feb; 48():69-75. PubMed ID: 26772401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD51 is an independent unfavorable prognostic factor in esophageal squamous cell carcinoma.
    Liu J; Han S; Hu R; Huang J; Zhang R; Li K; Li L; Zhang G; Zhao H
    Pathol Res Pract; 2018 Sep; 214(9):1352-1355. PubMed ID: 30049512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent prognostic role of PD-L1expression in patients with esophageal squamous cell carcinoma.
    Jiang D; Song Q; Wang H; Huang J; Wang H; Hou J; Li X; Xu Y; Sujie A; Zeng H; Tan L; Hou Y
    Oncotarget; 2017 Jan; 8(5):8315-8329. PubMed ID: 28039448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
    Wei R; Shang Z; Leng J; Cui L
    J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel long non-coding RNA FOXCUT and mRNA FOXC1 pair promote progression and predict poor prognosis in esophageal squamous cell carcinoma.
    Pan F; Yao J; Chen Y; Zhou C; Geng P; Mao H; Fang X
    Int J Clin Exp Pathol; 2014; 7(6):2838-49. PubMed ID: 25031703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma.
    Liu L; Yang Z; Ni W; Xuan Y
    Exp Mol Pathol; 2018 Apr; 104(2):134-139. PubMed ID: 29475036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological significance of wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma.
    Deng F; Zhou K; Cui W; Liu D; Ma Y
    Int J Clin Exp Pathol; 2015; 8(3):3045-53. PubMed ID: 26045816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIM-3 promotes the metastasis of esophageal squamous cell carcinoma by targeting epithelial-mesenchymal transition via the Akt/GSK-3β/Snail signaling pathway.
    Shan B; Man H; Liu J; Wang L; Zhu T; Ma M; Xv Z; Chen X; Yang X; Li P
    Oncol Rep; 2016 Sep; 36(3):1551-61. PubMed ID: 27430162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of GRB2 is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Li LY; Li EM; Wu ZY; Cao HH; Shen JH; Xu XE; Chen B; Wu JY; Xu LY
    Int J Clin Exp Pathol; 2014; 7(6):3132-40. PubMed ID: 25031732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vav1 expression is increased in esophageal squamous cell carcinoma and indicates poor prognosis.
    Zhu X; Jin H; Xia Z; Wu X; Yang M; Zhang H; Shang X; Cheng R; Zhan Z; Yu Z
    Biochem Biophys Res Commun; 2017 Apr; 486(2):571-576. PubMed ID: 28336434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
    Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
    PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of CD9 correlates with tumor stage and lymph node metastasis in esophageal squamous cell carcinoma.
    Huan J; Gao Y; Xu J; Sheng W; Zhu W; Zhang S; Cao J; Ji J; Zhang L; Tian Y
    Int J Clin Exp Pathol; 2015; 8(3):3054-61. PubMed ID: 26045817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway.
    Xu F; Xu CZ; Gu J; Liu X; Liu R; Huang E; Yuan Y; Zhao G; Jiang J; Xu C; Chu Y; Lu C; Ge D
    Oncotarget; 2016 Jul; 7(28):43401-43411. PubMed ID: 27270324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.
    Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I
    Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-455-3p acts as a prognostic marker and inhibits the proliferation and invasion of esophageal squamous cell carcinoma by targeting FAM83F.
    Yang H; Wei YN; Zhou J; Hao TT; Liu XL
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3200-3206. PubMed ID: 28770965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of δ-catenin in esophageal squamous cell carcinoma and its correlations with prognosis of patients.
    Zhang JY; Bai CY; Bai YQ; Zhang JY; Wu ZY; Wang SH; Xu XE; Wu JY; Zhu Y; Rui Y; Li EM; Xu LY
    Hum Pathol; 2014 Oct; 45(10):2014-22. PubMed ID: 25090917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of lymph node metastasis in esophageal squamous cell carcinoma.
    Wang H; Deng F; Liu Q; Ma Y
    Pathol Res Pract; 2017 Jul; 213(7):842-847. PubMed ID: 28554754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulated ataxia-telangiectasia group D complementing gene correlates with poor prognosis in patients with esophageal squamous cell carcinoma.
    Lai W; Zhao J; Zhang C; Cui D; Lin J; He Y; Zheng H; Wu X; Yang M
    Dis Esophagus; 2013; 26(8):817-22. PubMed ID: 23020249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma.
    Guo W; Dong Z; Cui J; Guo Y; Shen S; Guo X; Kuang G
    Clin Exp Metastasis; 2016 Jan; 33(1):73-85. PubMed ID: 26482475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of EGFR family expression in lymph node-negative esophageal squamous cell carcinoma patients.
    Yu W; Yang X; Chu L; Zhao K; Chen H; Xiang J; Zhang Y; Li H; Zhao W; Sun M; Wei Q; Fu X; Xie C; Zhu Z
    Pathol Res Pract; 2018 Jul; 214(7):1017-1023. PubMed ID: 29729836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.